The “Post-Acute Care Industry Trend Report” used data from Medicare Part A and Part B claims and Medicare Advantage data through November 2022. The report found “a more erratic trend [in FFS admissions] due to the lasting impacts of the COVID-19 pandemic.”
Here are seven key findings:
- National fee-for-service enrollment continued in a downward trend, decreasing by 3.4 percent, or 1.3 million people, between 2021 and 2022.
- Medicare Advantage enrollment increased by 29.6 million in 2022, and 46.2 percent of eligible beneficiaries enrolled in Medicare Advantage plans.
- Medicare Advantage plans could reach 50 percent as soon as 2024, the report predicted.
- Medicare Advantage enrollment increased 10 percent between 2021 and 2022 compared with 2.3 percent increase in the Medicare-eligible population.
- FFS admission remained stable for hospice, with only a 0.1 percent decrease.
- Year over year, FSS admission fell by 8.6 percent for home health.
- Inpatient utilization of home health, hospice and skilled nursing agencies moved closer to pre-pandemic levels, along with FSS inpatient discharge instructional rates.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
